---
title: "Zimmer Biomet: Adding To The Growth Profile"
date: "2025-02-07 14:45:34"
summary: "jetcityimage  When shares of Zimmer Biomet (NYSE:ZBH) moved down to the $105 mark in September, I believed that real value was showing up. Shares sold off despite the projection of mid-single digit sales growth, improved cash flows and higher earnings growth, driven by recent M&amp;A"
categories:
  - "seekalpha_articles"
lang:
  - "en"
translations:
  - "en"
tags:
  - "seekalpha_articles"
menu: ""
thumbnail: "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1488373546/image_1488373546.jpg"
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

![Zimmer Biomet headquarters. Zimmer Biomet produces artificial bone joints and dental prostheses.](https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1488373546/image_1488373546.jpg?io=getty-c-w750)



jetcityimage





When shares of **Zimmer Biomet (NYSE:[ZBH](https://seekingalpha.com/symbol/ZBH "Zimmer Biomet Holdings, Inc."))** moved down to the $105 mark in September, I believed that real value was showing up. Shares sold off despite the projection of mid-single digit sales growth, improved cash flows and higher earnings growth, driven by recent M&A

[seekalpha_articles](https://seekingalpha.com/article/4755997-zimmer-biomet-adding-to-growth-profile)
